 | • レポートコード：MRC2-11QY04033 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は眼炎症治療のグローバル市場について調査・分析したレポートです。種類別（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤）市場規模、用途別（小売薬局、病院薬局、オンライン薬局、ドラッグストア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別眼炎症治療の競争状況、市場シェア ・世界の眼炎症治療市場：種類別市場規模 2015年-2020年（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤） ・世界の眼炎症治療市場：種類別市場規模予測 2021年-2026年（免疫抑制剤、モノクローナル抗体、コルチコステロイド、毛様体筋麻痺薬、抗生物質、鎮痛剤、抗ウイルス剤、抗真菌剤） ・世界の眼炎症治療市場：用途別市場規模 2015年-2020年（小売薬局、病院薬局、オンライン薬局、ドラッグストア） ・世界の眼炎症治療市場：用途別市場規模予測 2021年-2026年（小売薬局、病院薬局、オンライン薬局、ドラッグストア） ・北米の眼炎症治療市場分析：米国、カナダ ・ヨーロッパの眼炎症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの眼炎症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の眼炎症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの眼炎症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan Plc.、Cipla Ltd.、Pfizer, Inc.、Novartis AG、Valeant Pharmaceuticals International, Inc.、Alimera Sciences, Inc.、Akorn, Inc.、Abbvie, Inc.、Eyegate Pharmaceuticals, Inc.、pSivida Corporation ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration.
The global market for ocular inflammation treatment is expected to grow sharply in the coming years. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.
Market Analysis and Insights: Global Ocular Inflammation Treatment Market
The global Ocular Inflammation Treatment market size is projected to reach US$ 21460 million by 2026, from US$ 20230 million in 2020, at a CAGR of 5.5%% during 2021-2026.
Global Ocular Inflammation Treatment Scope and Market Size
Ocular Inflammation Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ocular Inflammation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan Plc.
Cipla Ltd.
Pfizer, Inc.
Novartis AG
Valeant Pharmaceuticals International, Inc.
Alimera Sciences, Inc.
Akorn, Inc.
Abbvie, Inc.
Eyegate Pharmaceuticals, Inc.
pSivida Corporation
Market segment by Type, the product can be split into
Immunosuppressant
Monoclonal Antibodies
Corticosteroids
Cycloplegic Agents
Antibiotics
Analgesics
Antivirals
Antifungal
Market segment by Application, split into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Drug Stores
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Ocular Inflammation Treatment Revenue
1.4 Market by Type
1.4.1 Global Ocular Inflammation Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Immunosuppressant
1.4.3 Monoclonal Antibodies
1.4.4 Corticosteroids
1.4.5 Cycloplegic Agents
1.4.6 Antibiotics
1.4.7 Analgesics
1.4.8 Antivirals
1.4.9 Antifungal
1.5 Market by Application
1.5.1 Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Online Pharmacies
1.5.5 Drug Stores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Ocular Inflammation Treatment Market Perspective (2015-2026)
2.2 Global Ocular Inflammation Treatment Growth Trends by Regions
2.2.1 Ocular Inflammation Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Ocular Inflammation Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Ocular Inflammation Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Ocular Inflammation Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Ocular Inflammation Treatment Players by Market Size
3.1.1 Global Top Ocular Inflammation Treatment Players by Revenue (2015-2020)
3.1.2 Global Ocular Inflammation Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Ocular Inflammation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Ocular Inflammation Treatment Market Concentration Ratio
3.2.1 Global Ocular Inflammation Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Ocular Inflammation Treatment Revenue in 2019
3.3 Ocular Inflammation Treatment Key Players Head office and Area Served
3.4 Key Players Ocular Inflammation Treatment Product Solution and Service
3.5 Date of Enter into Ocular Inflammation Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Ocular Inflammation Treatment Historic Market Size by Type (2015-2020)
4.2 Global Ocular Inflammation Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Ocular Inflammation Treatment Market Size by Application (2015-2020)
5.2 Global Ocular Inflammation Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Ocular Inflammation Treatment Market Size (2015-2020)
6.2 Ocular Inflammation Treatment Key Players in North America (2019-2020)
6.3 North America Ocular Inflammation Treatment Market Size by Type (2015-2020)
6.4 North America Ocular Inflammation Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Ocular Inflammation Treatment Market Size (2015-2020)
7.2 Ocular Inflammation Treatment Key Players in Europe (2019-2020)
7.3 Europe Ocular Inflammation Treatment Market Size by Type (2015-2020)
7.4 Europe Ocular Inflammation Treatment Market Size by Application (2015-2020)
8 China
8.1 China Ocular Inflammation Treatment Market Size (2015-2020)
8.2 Ocular Inflammation Treatment Key Players in China (2019-2020)
8.3 China Ocular Inflammation Treatment Market Size by Type (2015-2020)
8.4 China Ocular Inflammation Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Ocular Inflammation Treatment Market Size (2015-2020)
9.2 Ocular Inflammation Treatment Key Players in Japan (2019-2020)
9.3 Japan Ocular Inflammation Treatment Market Size by Type (2015-2020)
9.4 Japan Ocular Inflammation Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Ocular Inflammation Treatment Market Size (2015-2020)
10.2 Ocular Inflammation Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020)
11 India
11.1 India Ocular Inflammation Treatment Market Size (2015-2020)
11.2 Ocular Inflammation Treatment Key Players in India (2019-2020)
11.3 India Ocular Inflammation Treatment Market Size by Type (2015-2020)
11.4 India Ocular Inflammation Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Ocular Inflammation Treatment Market Size (2015-2020)
12.2 Ocular Inflammation Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Ocular Inflammation Treatment Market Size by Type (2015-2020)
12.4 Central & South America Ocular Inflammation Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan Plc.
13.1.1 Allergan Plc. Company Details
13.1.2 Allergan Plc. Business Overview
13.1.3 Allergan Plc. Ocular Inflammation Treatment Introduction
13.1.4 Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020))
13.1.5 Allergan Plc. Recent Development
13.2 Cipla Ltd.
13.2.1 Cipla Ltd. Company Details
13.2.2 Cipla Ltd. Business Overview
13.2.3 Cipla Ltd. Ocular Inflammation Treatment Introduction
13.2.4 Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.2.5 Cipla Ltd. Recent Development
13.3 Pfizer, Inc.
13.3.1 Pfizer, Inc. Company Details
13.3.2 Pfizer, Inc. Business Overview
13.3.3 Pfizer, Inc. Ocular Inflammation Treatment Introduction
13.3.4 Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.3.5 Pfizer, Inc. Recent Development
13.4 Novartis AG
13.4.1 Novartis AG Company Details
13.4.2 Novartis AG Business Overview
13.4.3 Novartis AG Ocular Inflammation Treatment Introduction
13.4.4 Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.4.5 Novartis AG Recent Development
13.5 Valeant Pharmaceuticals International, Inc.
13.5.1 Valeant Pharmaceuticals International, Inc. Company Details
13.5.2 Valeant Pharmaceuticals International, Inc. Business Overview
13.5.3 Valeant Pharmaceuticals International, Inc. Ocular Inflammation Treatment Introduction
13.5.4 Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.5.5 Valeant Pharmaceuticals International, Inc. Recent Development
13.6 Alimera Sciences, Inc.
13.6.1 Alimera Sciences, Inc. Company Details
13.6.2 Alimera Sciences, Inc. Business Overview
13.6.3 Alimera Sciences, Inc. Ocular Inflammation Treatment Introduction
13.6.4 Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.6.5 Alimera Sciences, Inc. Recent Development
13.7 Akorn, Inc.
13.7.1 Akorn, Inc. Company Details
13.7.2 Akorn, Inc. Business Overview
13.7.3 Akorn, Inc. Ocular Inflammation Treatment Introduction
13.7.4 Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.7.5 Akorn, Inc. Recent Development
13.8 Abbvie, Inc.
13.8.1 Abbvie, Inc. Company Details
13.8.2 Abbvie, Inc. Business Overview
13.8.3 Abbvie, Inc. Ocular Inflammation Treatment Introduction
13.8.4 Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.8.5 Abbvie, Inc. Recent Development
13.9 Eyegate Pharmaceuticals, Inc.
13.9.1 Eyegate Pharmaceuticals, Inc. Company Details
13.9.2 Eyegate Pharmaceuticals, Inc. Business Overview
13.9.3 Eyegate Pharmaceuticals, Inc. Ocular Inflammation Treatment Introduction
13.9.4 Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.9.5 Eyegate Pharmaceuticals, Inc. Recent Development
13.10 pSivida Corporation
13.10.1 pSivida Corporation Company Details
13.10.2 pSivida Corporation Business Overview
13.10.3 pSivida Corporation Ocular Inflammation Treatment Introduction
13.10.4 pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020)
13.10.5 pSivida Corporation Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Ocular Inflammation Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Ocular Inflammation Treatment Revenue
Table 3. Ranking of Global Top Ocular Inflammation Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Ocular Inflammation Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Immunosuppressant
Table 6. Key Players of Monoclonal Antibodies
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Cycloplegic Agents
Table 9. Key Players of Antibiotics
Table 10. Key Players of Analgesics
Table 11. Key Players of Antivirals
Table 12. Key Players of Antifungal
Table 13. Global Ocular Inflammation Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Ocular Inflammation Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Ocular Inflammation Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Ocular Inflammation Treatment Market Share by Regions (2015-2020)
Table 17. Global Ocular Inflammation Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Ocular Inflammation Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Ocular Inflammation Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Ocular Inflammation Treatment Players
Table 24. Global Ocular Inflammation Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Ocular Inflammation Treatment Market Share by Players (2015-2020)
Table 26. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2019)
Table 27. Global Ocular Inflammation Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Ocular Inflammation Treatment Product Solution and Service
Table 30. Date of Enter into Ocular Inflammation Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Ocular Inflammation Treatment Market Size Share by Type (2015-2020)
Table 34. Global Ocular Inflammation Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Ocular Inflammation Treatment Market Size Share by Application (2015-2020)
Table 36. Global Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Ocular Inflammation Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 40. North America Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 42. North America Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 46. Europe Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 48. Europe Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 52. China Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 54. China Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 58. Japan Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 60. Japan Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 64. Southeast Asia Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 70. India Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 72. India Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Ocular Inflammation Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Ocular Inflammation Treatment Market Share (2019-2020)
Table 76. Central & South America Ocular Inflammation Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Ocular Inflammation Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Ocular Inflammation Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Ocular Inflammation Treatment Market Share by Application (2015-2020)
Table 80. Allergan Plc. Company Details
Table 81. Allergan Plc. Business Overview
Table 82. Allergan Plc. Product
Table 83. Allergan Plc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 84. Allergan Plc. Recent Development
Table 85. Cipla Ltd. Company Details
Table 86. Cipla Ltd. Business Overview
Table 87. Cipla Ltd. Product
Table 88. Cipla Ltd. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 89. Cipla Ltd. Recent Development
Table 90. Pfizer, Inc. Company Details
Table 91. Pfizer, Inc. Business Overview
Table 92. Pfizer, Inc. Product
Table 93. Pfizer, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer, Inc. Recent Development
Table 95. Novartis AG Company Details
Table 96. Novartis AG Business Overview
Table 97. Novartis AG Product
Table 98. Novartis AG Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 99. Novartis AG Recent Development
Table 100. Valeant Pharmaceuticals International, Inc. Company Details
Table 101. Valeant Pharmaceuticals International, Inc. Business Overview
Table 102. Valeant Pharmaceuticals International, Inc. Product
Table 103. Valeant Pharmaceuticals International, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 104. Valeant Pharmaceuticals International, Inc. Recent Development
Table 105. Alimera Sciences, Inc. Company Details
Table 106. Alimera Sciences, Inc. Business Overview
Table 107. Alimera Sciences, Inc. Product
Table 108. Alimera Sciences, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 109. Alimera Sciences, Inc. Recent Development
Table 110. Akorn, Inc. Company Details
Table 111. Akorn, Inc. Business Overview
Table 112. Akorn, Inc. Product
Table 113. Akorn, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 114. Akorn, Inc. Recent Development
Table 115. Abbvie, Inc. Business Overview
Table 116. Abbvie, Inc. Product
Table 117. Abbvie, Inc. Company Details
Table 118. Abbvie, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 119. Abbvie, Inc. Recent Development
Table 120. Eyegate Pharmaceuticals, Inc. Company Details
Table 121. Eyegate Pharmaceuticals, Inc. Business Overview
Table 122. Eyegate Pharmaceuticals, Inc. Product
Table 123. Eyegate Pharmaceuticals, Inc. Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 124. Eyegate Pharmaceuticals, Inc. Recent Development
Table 125. pSivida Corporation Company Details
Table 126. pSivida Corporation Business Overview
Table 127. pSivida Corporation Product
Table 128. pSivida Corporation Revenue in Ocular Inflammation Treatment Business (2015-2020) (Million US$)
Table 129. pSivida Corporation Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ocular Inflammation Treatment Market Share by Type: 2020 VS 2026
Figure 2. Immunosuppressant Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Corticosteroids Features
Figure 5. Cycloplegic Agents Features
Figure 6. Antibiotics Features
Figure 7. Analgesics Features
Figure 8. Antivirals Features
Figure 9. Antifungal Features
Figure 10. Global Ocular Inflammation Treatment Market Share by Application: 2020 VS 2026
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Online Pharmacies Case Studies
Figure 14. Drug Stores Case Studies
Figure 15. Ocular Inflammation Treatment Report Years Considered
Figure 16. Global Ocular Inflammation Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Ocular Inflammation Treatment Market Share by Regions: 2020 VS 2026
Figure 18. Global Ocular Inflammation Treatment Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Ocular Inflammation Treatment Market Share by Players in 2019
Figure 21. Global Top Ocular Inflammation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ocular Inflammation Treatment as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Ocular Inflammation Treatment Revenue in 2019
Figure 23. North America Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Ocular Inflammation Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
キャッスルマン病治療の世界市場（～2026年） Castleman disease is a rare condition of lymph nodes and similar tissues. This condition occurs when too many non-cancer cells started to grow in the lymph node. After initial growth hard growth started to form. Usually, it occurs in the chest, abdomen or neck. This condition is also called as angio…- 副鼻腔炎治療の世界市場（～2026年） The sinuses are a connected system of air-filled cavities located in the skull. Sinusitis is an inflammation of the sinus lining caused by bacteria, viruses, fungi, and microbes. Increase in upper respiratory tract infections and rise in incidence of chronic rhinosinusitis (CRS) across the world are…
- 感覚異常治療の世界市場（～2026年） Paresthesia is an abnormal sensation such as tingling, tickling, pricking, numbness or burning of a person's skin with no apparent physical cause. The manifestation of a paresthesia may be transient or chronic, and may have any of dozens of possible underlying causes. The most familiar kind of pares…
- 持続性顔面紅斑治療の世界市場（～2026年） Facial erythema is a very common reason for consulting a dermatologist. While often a manifestation of a benign condition, in some cases facial erythema may be the first sign of a more serious disorder and specific diagnostic tests are needed to rule out these diseases. Market Analysis and Insights:…
- 早期陣痛治療の世界市場（～2026年） Preterm labor is defined as regular contractions of the uterus resulting in changes in the cervix that start before 37 weeks of pregnancy. Increase in premature birth cases and rapid increase birthrate are major driving factors of preterm labor treatment market. Market Analysis and Insights: Global …